To evaluate the Safety and efficacy of Unani formulation in the treatment of Dyspepsia
Phase 2
- Conditions
- Health Condition 1: K30- Functional dyspepsiaHealth Condition 2: null- SÅ«â?? al-Hadm (Dyspepsia)
- Registration Number
- CTRI/2015/02/005528
- Lead Sponsor
- Central Council for Research in Unani Medicine CCRUM New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 300
Inclusion Criteria
1.Patients of either sex in the age group of 18-55 years.
2.Patients having abdominal discomfort with any of the following symptoms of SÅ«â?? al-Hadm (Dyspepsia) due to SÅ«â??-i-MizÄ?j BÄ?rid:
•Abdominal pain
•Heartburn
•Acid Regurgitation
•Eructation
•Nausea and Vomiting
•Abdominal Distention
Exclusion Criteria
•Dysphagia
•Inflammatory Bowel Disease e.g. Ulcerative colitis, Crohnâ??s Disease
•Palpable abdominal mass
•History of Zollinger ellison syndrome
•History of sudden weight loss
•History of long-term medication
•Known cases of cancer, anaemia/ haematemesis/ melaena
•Known cases of severe hepatic, renal or cardiac ailments
•Diabetes Mellitus
•H/o addiction (tobacco chewing, smoking, alcohol, drugs)
•Pregnancy and lactation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in signs and symptoms of SÅ«â?? al-Hadm (Dyspepsia)Timepoint: 2 weeks
- Secondary Outcome Measures
Name Time Method Haematological and biochemical assessment for safety assessmentTimepoint: 2 weeks